Ningxia Qiyuan Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TETRACYCLINE HYDROCHLORIDE, with a corresponding US DMF Number 22356.
Remarkably, this DMF maintains an Active status since its submission on December 19, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 16, 2014, and payment made on April 30, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II